| Completed | Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protoc NCT04109391 | Tanvex BioPharma USA, Inc. | Phase 3 |
| Withdrawn | Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Can NCT03091842 | University of Southern California | N/A |
| Active Not Recruiting | Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectabl NCT03971409 | Laura Huppert, MD, BA | Phase 2 |
| Terminated | Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen R NCT03566485 | Vanderbilt-Ingram Cancer Center | Phase 1 / Phase 2 |
| Completed | Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer NCT03556358 | Tanvex BioPharma USA, Inc. | Phase 3 |
| Active Not Recruiting | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa B NCT03414970 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668 | Rutgers, The State University of New Jersey | N/A |
| Completed | 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients W NCT03364348 | George W. Sledge Jr. | Phase 1 |
| Completed | Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy NCT03102866 | Ohio State University Comprehensive Cancer Center | N/A |
| Terminated | Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors NCT03284346 | University of Southern California | N/A |
| Terminated | Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage NCT03128619 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resi NCT02860000 | Mayo Clinic | Phase 2 |
| Unknown | Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hor NCT03044730 | Northwestern University | Phase 2 |
| Completed | Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer NCT03139435 | Wake Forest University Health Sciences | N/A |
| Completed | Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery NCT03188393 | NRG Oncology | Phase 2 |
| Unknown | Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breas NCT03025139 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hor NCT02760030 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Active Not Recruiting | Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca NCT02957968 | Virginia Commonwealth University | Phase 2 |
| Completed | Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors NCT02897375 | Emory University | Phase 1 |
| Completed | S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) NCT02728596 | SWOG Cancer Research Network | N/A |
| Completed | Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative NCT02780401 | University of Washington | Phase 1 |
| Completed | MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Brea NCT02702830 | Wake Forest University Health Sciences | — |
| Completed | Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-I NCT03050463 | Stanford University | — |
| Active Not Recruiting | Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breas NCT02827877 | City of Hope Medical Center | Phase 2 |
| Completed | Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin NCT02677389 | University of Wisconsin, Madison | N/A |
| Completed | Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors NCT02662335 | Fred Hutchinson Cancer Center | N/A |
| Completed | eHealth Weight Loss Program in African American Breast Cancer Survivors NCT02699983 | Rutgers, The State University of New Jersey | N/A |
| Completed | Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer NCT02432950 | City of Hope Medical Center | N/A |
| Completed | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations NCT02646319 | Mayo Clinic | EARLY_Phase 1 |
| Active Not Recruiting | Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy NCT02445391 | ECOG-ACRIN Cancer Research Group | Phase 3 |
| Completed | Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity NCT02566408 | Case Comprehensive Cancer Center | N/A |
| Terminated | High-Intensity Interval Training for Stage I-III Breast Cancer Patients NCT02454777 | University of Southern California | N/A |
| Completed | Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering NCT03061175 | Rutgers, The State University of New Jersey | N/A |
| Completed | Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors NCT03198286 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Active Not Recruiting | Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating NCT02488967 | NRG Oncology | Phase 3 |
| Completed | 18F-FSPG PET/CT for Cancer Patients on Therapy NCT02599194 | Andrei Iagaru | Phase 2 |
| Completed | Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III NCT02203552 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Active Not Recruiting | Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer NCT02157051 | University of Washington | Phase 1 |
| Completed | Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors NCT03039140 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Canc NCT02400060 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating P NCT02315196 | Rutgers, The State University of New Jersey | Phase 2 |
| Completed | Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer NCT02370277 | University of Southern California | — |
| Withdrawn | KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Ca NCT02168179 | Wake Forest University Health Sciences | N/A |
| Terminated | Phase II Study of Everolimus Beyond Progression NCT02269670 | Emory University | Phase 2 |
| Terminated | Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kid NCT02273752 | Emory University | Phase 2 |
| Completed | Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors NCT02235051 | City of Hope Medical Center | N/A |
| Completed | BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx NCT02038010 | Northwestern University | Phase 1 |
| Terminated | Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Rad NCT02023008 | Wake Forest University Health Sciences | N/A |
| Completed | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Pos NCT02060253 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Active Not Recruiting | Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing NCT01953588 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Active Not Recruiting | Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Ca NCT01901094 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Ch NCT02002533 | Gary Morrow | N/A |
| Completed | Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer NCT02415387 | Ohio State University Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cance NCT01941784 | Wake Forest University Health Sciences | N/A |
| Terminated | PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer NCT01712815 | University of Southern California | N/A |
| Completed | Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer NCT01869764 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III NCT01959490 | Case Comprehensive Cancer Center | Phase 2 |
| Active Not Recruiting | Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With NCT01730833 | City of Hope Medical Center | Phase 2 |
| Terminated | Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Bre NCT01868503 | Stanford University | Phase 2 |
| Active Not Recruiting | A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) NCT01824836 | ECOG-ACRIN Cancer Research Group | N/A |
| Terminated | Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer NCT01897441 | Albert Einstein College of Medicine | N/A |
| Completed | Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors NCT01849250 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery NCT01754519 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Br NCT01818063 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis NCT01806675 | Sanjiv Sam Gambhir | Phase 1 / Phase 2 |
| Terminated | Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III NCT01776008 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Brea NCT01750073 | University of Nebraska | Phase 2 |
| Terminated | Light-Scattering Spectroscopy for Detection of Breast Cancer NCT01755208 | University of Southern California | N/A |
| Terminated | Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Br NCT02370264 | University of Southern California | N/A |
| Completed | Phase I: At-Home Support for Rural Women Using Group Video Calling NCT01672684 | Stanford University | Phase 1 |
| Withdrawn | Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer NCT01695057 | University of Southern California | N/A |
| Terminated | Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors NCT01628887 | City of Hope Medical Center | N/A |
| Completed | Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri NCT01606241 | Mayo Clinic | Phase 1 |
| Completed | Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer NCT01632332 | Mayo Clinic | Phase 1 |
| Completed | Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer NCT01688609 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Exercise Program for Early Breast Cancer Survivors NCT01140282 | University of Southern California | N/A |
| Withdrawn | Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant NCT01558778 | Roswell Park Cancer Institute | N/A |
| Completed | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820 | Roswell Park Cancer Institute | Phase 1 |
| Active Not Recruiting | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients Wit NCT01525966 | City of Hope Medical Center | Phase 2 |
| Terminated | PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Br NCT01697293 | Prescient Therapeutics, Ltd. | Phase 1 / Phase 2 |
| Completed | Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery NCT01483196 | Wake Forest University Health Sciences | N/A |
| Completed | Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer NCT01493310 | University of Chicago | Phase 1 |
| Terminated | FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer NCT01931709 | University of Washington | N/A |
| Completed | Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastroz NCT01478477 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Nega NCT01928186 | University of Washington | N/A |
| Terminated | Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive NCT01368263 | Washington University School of Medicine | Phase 2 |
| Unknown | Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients NCT01372579 | Northwestern University | Phase 2 |
| Terminated | Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer NCT01394211 | University of Arizona | Phase 2 |
| Completed | Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER NCT01355393 | University of Washington | Phase 1 / Phase 2 |
| Terminated | MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer NCT01319539 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Bre NCT01293032 | Virginia Commonwealth University | N/A |
| Completed | Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms NCT01194440 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Diindolylmethane in Treating Patients With Breast Cancer NCT01391689 | University of Arizona | N/A |
| Withdrawn | Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer NCT01729832 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing NCT01982591 | Fox Chase Cancer Center | — |
| Withdrawn | Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By NCT01292083 | University of Southern California | N/A |
| Completed | Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer NCT01417286 | Rutgers, The State University of New Jersey | Phase 2 |
| Terminated | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Tr NCT01238133 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Recei NCT01243541 | Northwestern University | N/A |
| Terminated | RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III NCT01208441 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors NCT01233505 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery NCT01234532 | University of Maryland, Baltimore | Phase 2 |
| Terminated | Endoscopic Breast Surgery in Treating Patients With Breast Cancer NCT01222377 | University of Southern California | N/A |
| Terminated | Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload NCT01159067 | City of Hope Medical Center | Phase 2 |
| Completed | Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer NCT01219075 | University of Southern California | N/A |
| Completed | Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors NCT01113554 | Wake Forest University Health Sciences | N/A |
| Completed | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 | University of Southern California | Phase 1 |
| Completed | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors NCT01158274 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, o NCT01151449 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy NCT01487954 | Case Comprehensive Cancer Center | Phase 2 |
| Terminated | Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Ca NCT01051401 | Wake Forest University Health Sciences | Phase 1 |
| Terminated | Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Rece NCT01050075 | City of Hope Medical Center | N/A |
| Completed | Window of Opportunity Study Targeting the Inflammatory Milieu NCT01881048 | University of Colorado, Denver | EARLY_Phase 1 |
| Completed | MUC1 Vaccine for Triple-negative Breast Cancer NCT00986609 | Joseph Baar, MD, PhD | EARLY_Phase 1 |
| Completed | Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Rela NCT01013337 | Abramson Cancer Center at Penn Medicine | N/A |
| Completed | Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients NCT01723943 | University of Washington | N/A |
| Completed | Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer NCT00572728 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant NCT00795769 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breas NCT00679029 | University of Nebraska | Phase 2 |
| Completed | Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting NCT00618657 | University of California, Irvine | Phase 2 |
| Completed | Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer NCT00516243 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Ca NCT00513292 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patie NCT00513695 | University of Washington | Phase 2 |
| Completed | Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer NCT00470301 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That NCT00450879 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole NCT00416715 | University of Washington | Phase 2 |
| Completed | Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breas NCT01043003 | City of Hope Medical Center | N/A |
| Completed | Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem NCT00408681 | Fred Hutchinson Cancer Center | N/A |
| Completed | Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanopart NCT00407888 | University of Washington | Phase 2 |
| Completed | Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in NCT00343863 | University of Washington | N/A |
| Completed | Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer NCT00119262 | National Cancer Institute (NCI) | Phase 2 |
| Completed | ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment NCT00425672 | University of Washington | Phase 1 / Phase 2 |
| Terminated | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA B NCT00194792 | University of Washington | Phase 2 |
| Completed | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating NCT00066690 | ETOP IBCSG Partners Foundation | Phase 3 |
| Completed | Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer T NCT00194779 | University of Washington | Phase 2 |
| Completed | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic S NCT00070252 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Canc NCT00063934 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer NCT00060372 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer NCT00070057 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer NCT00049114 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer NCT00146588 | Craig A. Bunnell, MD, MPH | N/A |
| Completed | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer NCT00028496 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients W NCT00378313 | NSABP Foundation Inc | Phase 2 |
| Completed | Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer NCT00436254 | University of Washington | Phase 1 |
| Terminated | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treati NCT00016276 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer NCT00019643 | National Institutes of Health Clinical Center (CC) | — |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Po NCT00080613 | Robert H. Lurie Cancer Center | Phase 2 |